Pharmaceutical composition containing parcetamol
US4324778A · kind A · utility
6Cited by
0References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 29, 1980 |
| Grant date | Apr 13, 1982 |
| Priority date | — |
| Expiry date | Jan 29, 2000 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The acute liver toxicity effects of paracetamol are reduced by co-formulating with ascorbic acid derivatives (ascorbate anion bioprecursors) which produce high liver concentrations of ascorbate anion after oral administration of the co-formulation. A suitable ascorbate anion bioprecursor is ascorbyl 6-palmitate.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.